Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2020-10-01
2024-05-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatments for Recovery of Hand Function in Acute Stroke Survivors
NCT00565045
t-RNS After Hand Recovery in Chronic Stroke
NCT05489146
Assessment of a Physio-neuro Platform (SynPhNe) for Home-based Retraining of Hand Function in Stroke Survivors
NCT02896348
Optimizing Transcranial Direct Current Stimulation for Motor Recovery From Severe Post-stroke Hemiparesis
NCT04574973
Spinal Cord Stimulation for Restoration of Arm and Hand Function in People With Subcortical Stroke
NCT04512690
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Combined non-invasive brain and Functional Electrical Stimulation
In this arm of the study participants will receive repeated non-invasive brain stimulation synchronously paired with FES
Combined Non-invasive brain stimulation and functional electrical hand stimulation
Participants will receive synchronously combined non-invasive brain stimulation (delivered via electrical/magnetic stimulation) with functional electrical stimulation (delivered via DS7A or Neuromove) of the weak hand
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Combined Non-invasive brain stimulation and functional electrical hand stimulation
Participants will receive synchronously combined non-invasive brain stimulation (delivered via electrical/magnetic stimulation) with functional electrical stimulation (delivered via DS7A or Neuromove) of the weak hand
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Stroke onset of at least six months prior to the time of participation;
3. Ability to elicit motor evoked potential in the Extensor digitorum communis (EDC) muscle
4. Ability to grasp, as indicated by a score of at least 1 (out of 2) on the finger mass flexion and cylindrical grasp items of Upper Extremity Fugl-Meyer scale
5. age between 18-80 years
Exclusion Criteria
2. Excessive spasticity of wrist and finger muscles, defined as a Modified Ashworth Score more than or equal to 3, which may limit the ability to open the hand/fingers;
3. Diagnosis of neurological disorders other than stroke, which may confound the results;
4. Has touch and proprioceptive sensory deficits determined via a score of 0 on the position sense section (section H) of the Fugl Meyer Upper Extremity assessment proprioception, which may limit the ability to report excessive amount of tingling due to hand stimulation
5. History of seizure or epilepsy as the effects of TMS are not tested in individuals with seizures or epilepsy;
6. Orthopaedic/musculoskeletal conditions (eg, arthritis) affecting the upper extremity, which may limit the ability to move the affected hand
7. Presence of metallic implants in the head or neck for TMS;
8. Currently or planning to become pregnant, as the effects of TMS are not tested not pregnant women;
9. Difficulty maintaining alertness or remaining still for MRI;
10. Ferromagnetic metallic implants, pacemakers, other implanted devices, or ventilators (for MRI);
11. Bodyweight \> 300 lbs due to MRI scanner dimensions
12. Psychiatric diagnosis according to the criteria of the Diagnostic and Statistical Manual of Mental Disorder, Fifth Edition (DSM-V), or who are on psychotropic medication, which may confound the results
13. Cognitive impairments, defined as a score of \< 23 on the Mini Mental Status Examination, which may limit the ability to follow the commands in the study
14. Excessive pain \> equal to 5 on Visual Analog Scale in the more-affected upper extremity, which may limit the ability to participate in the study
15. History of schizophrenia, Bipolar disorder (type I or II) \[Answer yes to questions 16 and items of the (hypo) maniac module of the The Mini International Neuropsychiatric Interview\], current moderate, severe depression (Scores of \>10 on Patient Health Questionnaire-9) and other neurological or medical conditions that could confound results.
16. Life expectancy less than the duration of the study
17. Hemispatial neglect, which may limit the ability to pay attention to the affected hand
18. Participating in concurrent therapy, which may confound the results
19. We will exclude children because although stroke may occur in children, the protocol is addressing stoke in adults and the devices are not approved for use in children
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amit Sethi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amit Sethi
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amit Sethi
Role: PRINCIPAL_INVESTIGATOR
UPitt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Neuromotor Recovery and Rehabilitation Lab
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY19070157
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.